Lipase Enzymes for Sustainable Synthesis of Pharmaceuticals and Chiral Organic Building Blocks
Advanced Sustainable Systems · 2025-01 · 9 (1)
DOI: 10.1002/adsu.202400495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Sustainable Systems, online erschienen am 09.10.2024. Verfasst von Moumita Khanra und 2 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 138 Literaturangaben.
Abstract (Originalsprache)
Biocatalysis is a green and sustainable process for synthesizing chiral organic building blocks and active pharmaceutical ingredients (API). United Nations' Sustainable Development Goals 2030 advocates using green, sustainable, recyclable chemicals by industries to reduce environmental pollution. Pharmaceutical companies are adopting biocatalysis technologies for manufacturing chiral active pharmaceutical ingredients. The lipase‐catalyzed kinetic and dynamic‐kinetic resolution method is a pharmaceutically accepted process for manufacturing chiral API. This review describes the reported methods for synthesizing chiral API/KSM (Key Starting Material) molecules using lipase enzymes over the last ten years.
Zitieren
APA
Khanra, M., Ravichandiran, V., & Swain, S. P. (2025). Lipase Enzymes for Sustainable Synthesis of Pharmaceuticals and Chiral Organic Building Blocks. Advanced Sustainable Systems, 9(1). https://doi.org/10.1002/adsu.202400495
Vancouver
Khanra M, Ravichandiran V, Swain SP. Lipase Enzymes for Sustainable Synthesis of Pharmaceuticals and Chiral Organic Building Blocks. Advanced Sustainable Systems. 2025;9(1). doi:10.1002/adsu.202400495
BibTeX
@article{Khanra2025,
author = {Khanra, Moumita and Ravichandiran, V. and Swain, Sharada Prasanna},
title = {Lipase Enzymes for Sustainable Synthesis of Pharmaceuticals and Chiral Organic Building Blocks},
journal = {Advanced Sustainable Systems},
year = {2025},
volume = {9},
number = {1},
doi = {10.1002/adsu.202400495}
}
EUVIMED